DOCSLIB.ORG

The Ehlers-Danlos Syndrome: on Beyond Collagens

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Ehlers-Danlos Syndrome: on Beyond Collagens PERSPECTIVE SERIES Matricellular proteins E. Helene Sage, Series Editor The Ehlers-Danlos syndrome: on beyond collagens Jau-Ren Mao and James Bristow Department of Pediatrics and Cardiovascular Research Institute, University of California-San Francisco, San Francisco, California, USA Address correspondence to: James Bristow, University of California-San Francisco Laurel Heights Campus, 3333 California Street, Box 1245, Rm 150K, San Francisco, California 94118, USA. Phone: (415) 476-0911; Fax: (415) 476-3586; E-mail: [email protected]. The Ehlers-Danlos syndrome (EDS) is a clinically and remodeling. These processes are of critical importance genetically heterogeneous connective tissue disorder during development, wound healing, and aging. affecting as many as 1 in 5,000 individuals (1). EDS is characterized in its most common form by hyperexten- Collagen metabolism and molecular mechanisms sibility of the skin, hypermobility of joints often result- of EDS ing in dislocations, and tissue fragility exemplified by The concept that EDS is a disorder of fibrillar colla- easy bruising, atrophic scars following superficial injury, gen metabolism is well supported by identification and premature rupture of membranes during pregnan- of specific defects in the collagen biosynthetic path- cy. The recognition of frequent ultrastructural abnor- way that produce clinically distinct forms of EDS. malities of collagen fibrils in EDS patients led to the These are briefly reviewed below and in Figure 1. For concept that EDS is a disorder of fibrillar collagen more complete reviews of collagen biochemistry and metabolism (2). Following the identification of specific clinical aspects of EDS, the reader is directed to mutations in the genes encoding collagen types I, III, recent reviews (1, 2). and V, as well as several collagen processing enzymes, There are three fundamental mechanisms of disease the EDS classification scheme was collapsed into six dis- known to produce EDS: deficiency of collagen-pro- tinct clinical syndromes (3), emphasizing the molecular cessing enzymes, dominant-negative effects of mutant basis of each form (Table 1). collagen α-chains, and haploinsufficiency. The two Heterogeneity between the several clinical syndromes known examples of deficient enzyme activity leading to both complicates the diagnosis of EDS and makes EDS are lysyl-hydroxylase deficiency and procollagen accurate diagnosis imperative. Ultimately, one would peptidase deficiency. In the first case, the inability to like to be able to establish a molecular diagnosis for hydroxylate lysine residues precludes normal inter- each EDS patient. This is a laudable goal because it may molecular cross-linking of collagen trimers, and in the allow improved genetic counseling through correlation second instance, absence of procollagen peptidase pre- of mutant genotypes with specific outcomes or com- vents normal proteolytic cleavage of the NH2-terminus plications. However, as outlined below, the molecular of procollagen chains. In both circumstances the mor- defects described to date are not sufficient to explain phology and strength of the collagen fibril is compro- disease in many EDS patients, including those with the mised (Figure 2b), explaining the severe and early clin- most common classical and hypermobility types. As a ical findings. Because half-normal enzyme activity is result, the search for EDS genes recently has expanded sufficient for normal collagen processing, both of these beyond the collagens and collagen-modifying genes. An conditions are recessive. understanding of the complete complement of genes Dominant-negative mutations in collagen I, III, and V and proteins involved in EDS and the precise mecha- cause several different forms of EDS (Figure 1). The nisms by which they cause disease may teach us much most clinically significant of these are COL3A1 muta- about normal collagenous matrix deposition and tions causing the potentially lethal vascular form of Table 1 The Villefranche classification of EDS EDS type Clinical findings Inheritance Gene defects Classical (I/II) Skin and joint hypermobility, atrophic scars, easy bruising Autosomal dominant COL5A1, COL5A2 Hypermobility (III) Joint hypermobility, pain, dislocations Autosomal dominant Unknown Vascular (IV) Thin skin, arterial or uterine rupture, bruising, small joint hyperextensibility Autosomal dominant COL3A1 Kyphoscoliosis (VI) Hypotonia, joint laxity, congenital scoliosis, ocular fragility Autosomal recessive Lysyl-hydroxylase Arthrochalasia (VIIa,b) Severe joint hypermobility, skin mild, scoliosis, bruising Autosomal dominant COL1A1, COL1A2 Dermatosparaxsis(VIIc) Severe skin fragility, cutis laxa, bruising Autosomal recessive Procollagen N-peptidase The Journal of Clinical Investigation | May 2001 | Volume 107 | Number 9 1063 Matricellular proteins PERSPECTIVE SERIES E. Helene Sage, Series Editor ease is still unknown. Because collagen III is an impor- tant component of the arterial and bowel walls, these tissues are also frequently affected. Exon-skipping and missense mutations in the COL5A1 and COL5A2 genes have also been reported to cause classical EDS (5, 6), presumably through domi- nant-negative effects. However, two recent reports demonstrated that COL5A1 haploinsufficiency appears to be more common (7, 8). These studies showed that one-third of a subset of classical EDS patients that could be evaluated (because they are heterozygous for polymorphisms of COL5A1) did not express the mutant allele. Mutant COL5A1 transcripts are pre- sumably degraded through non-sense–mediated RNA decay. Truncating mutations were identified subse- quently in most haploinsufficient patients. The dra- Figure 1 matic clinical effect of COL5A1 haploinsufficiency is The biosynthetic pathway for the fibrillar collagens expressed in skin, surprising, given that collagen V is a quite minor con- identifying steps that are affected in different forms of EDS. (I) Collagen stituent of collagen in skin, tendon, and ligament, but gene transcription is highly regulated, but haploinsufficiency for COL5A1 the clinical phenotype clearly supports an important is uncompensated and leads to a reduction in COL5A1 mRNA and α1(V) function for collagen V in the maintenance of biome- procollagen chains. This accounts for 30–50% of classical EDS cases. (II) chanical integrity of collagenous matrix. Many proline and lysine residues in the translated procollagen chains are One clearly established function of collagen V is lim- hydroxylated by lysyl- and proline hydroxylases. Hydroxylation is essen- itation of fibril diameter. When mixtures of denatured tial for subsequent crosslinking and lysyl-hydroxylase deficiency causes the kyphoscoliosis form of EDS. (III) Procollagen α-chains are assembled collagen I and collagen V are renatured in vitro, fibrils into trimers within the rough endoplasmic reticulum (RER). Mutations of smaller size are produced with increasing collagen V in COL3A1 that interrupt the triple helical structure prevent normal pro- content (9). Indeed, the ultrastructural hallmark of cessing and secretion of collagen III, causing the vascular form of EDS. classical EDS is a 25% increase in fibril diameter and (IV) In the ECM, the NH2- and COOH-terminal propeptides are cleaved rare composite fibrils, often called “collagen cauliflow- by specific peptidases. Dominant mutations in COL1A1 and COL1A2 can ers” (Figure 2c). While the effect of collagen V on fibril prevent cleavage and cause arthrochalasia, while recessive loss of the diameter is intrinsic to its structure and does not N-procollagen peptidase cause dermatosparaxis. (V) Collagen molecules require enzymatic activity or the presence of noncolla- self-assemble into heterotypic fibrils. Dominant-negative mutations in gen proteins, the mechanism by which collagen V reg- COL5A1 and COL5A2 alter fibril assembly and cause some cases of clas- ulates fibril size is uncertain. The α1(V) chain has a sical EDS. (VI) Collagen fibrils are deposited in tissue-specific arrange- ments in close association with many fibril-associated proteins and pro- larger than usual NH2-terminal nonhelical domain, teoglycans. Because new fibrils are laid down in close association with and pepsin cleavage of this domain eliminates the the fibroblast cell membrane, interactions between the fibril and the cell effect of collagen V on fibril diameter (10). Further, are important and may involve direct interaction with collagens and/or immunohistochemical studies demonstrate that the matricellular proteins, including tenascin-X (TNX). triple helical region of collagen V is buried within the fibril, and the amino terminus of α1(V) protrudes from the fibril surface. Because the amino terminus of α1(V) EDS. The reported COL3A1 mutations are either exon- contains numerous sulfated tyrosine residues, this skipping mutations or missense mutations that disrupt domain carries a significant negative charge. It is pos- the collagen triple helix (4). Because collagen III consists tulated that this domain’s bulk or negative charge den- of homotrimers and the normal and mutant pro α1(III) sity limits growth of the nascent fibril once a critical chains appear to be produced in equal abundance, near- number of collagen V trimers are incorporated. ly 90% of all α1(III) trimers will contain one or more It is not clear how the relatively minor abnormalities in mutant α-chains. Trimers containing mutant chains are fibril structure, often affecting less than 5% of fibrils, not secreted and are either
Load more

Recommended publications
  • Regulation of Procollagen Amino-Propeptide Processing During Mouse Embryogenesis by Specialization of Homologous ADAMTS Protease
    DEVELOPMENT AND DISEASE RESEARCH ARTICLE 1587 Development 133, 1587-1596 (2006) doi:10.1242/dev.02308 Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis Carine Le Goff1, Robert P. T. Somerville1, Frederic Kesteloot2, Kimerly Powell1, David E. Birk3, Alain C. Colige2 and Suneel S. Apte1,* Mutations in ADAMTS2, a procollagen amino-propeptidase, cause severe skin fragility, designated as dermatosparaxis in animals, and a subtype of the Ehlers-Danlos syndrome (dermatosparactic type or VIIC) in humans. Not all collagen-rich tissues are affected to the same degree, which suggests compensation by the ADAMTS2 homologs ADAMTS3 and ADAMTS14. In situ hybridization of Adamts2, Adamts3 and Adamts14, and of the genes encoding the major fibrillar collagens, Col1a1, Col2a1 and Col3a1, during mouse embryogenesis, demonstrated distinct tissue-specific, overlapping expression patterns of the protease and substrate genes. Adamts3, but not Adamts2 or Adamts14, was co-expressed with Col2a1 in cartilage throughout development, and with Col1a1 in bone and musculotendinous tissues. ADAMTS3 induced procollagen I processing in dermatosparactic fibroblasts, suggesting a role in procollagen I processing during musculoskeletal development. Adamts2, but not Adamts3 or Adamts14, was co-expressed with Col3a1 in many tissues including the lungs and aorta, and Adamts2–/– mice showed widespread defects in procollagen III processing. Adamts2–/– mice had abnormal lungs, characterized by a decreased parenchymal density. However, the aorta and collagen fibrils in the aortic wall appeared normal. Although Adamts14 lacked developmental tissue-specific expression, it was co-expressed with Adamts2 in mature dermis, which possibly explains the presence of some processed skin procollagen in dermatosparaxis.
    [Show full text]
  • Bruch's Membrane Abnormalities in PRDM5-Related Brittle Cornea
    Porter et al. Orphanet Journal of Rare Diseases (2015) 10:145 DOI 10.1186/s13023-015-0360-4 RESEARCH Open Access Bruch’s membrane abnormalities in PRDM5-related brittle cornea syndrome Louise F. Porter1,2,3, Roberto Gallego-Pinazo4, Catherine L. Keeling5, Martyna Kamieniorz5, Nicoletta Zoppi6, Marina Colombi6, Cecilia Giunta7, Richard Bonshek2,8, Forbes D. Manson1 and Graeme C. Black1,9* Abstract Background: Brittle cornea syndrome (BCS) is a rare, generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture. Recessive mutations in transcription factors ZNF469 and PRDM5 cause BCS. Both transcription factors are suggested to act on a common pathway regulating extracellular matrix genes, particularly fibrillar collagens. We identified bilateral myopic choroidal neovascularization as the presenting feature of BCS in a 26-year-old-woman carrying a novel PRDM5 mutation (p.Glu134*). We performed immunohistochemistry of anterior and posterior segment ocular tissues, as expression of PRDM5 in the eye has not been described, or the effects of PRDM5-associated disease on the retina, particularly the extracellular matrix composition of Bruch’smembrane. Methods: Immunohistochemistry using antibodies against PRDM5, collagens type I, III, and IV was performed on the eyes of two unaffected controls and two patients (both with Δ9-14 PRDM5). Expression of collagens, integrins, tenascin and fibronectin in skin fibroblasts of a BCS patient with a novel p.Glu134* PRDM5 mutation was assessed using immunofluorescence. Results: PRDM5 is expressed in the corneal epithelium and retina. We observe reduced expression of major components of Bruch’s membrane in the eyes of two BCS patients with a PRDM5 Δ9-14 mutation.
    [Show full text]
  • Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions, ADYU J SCI, 10(2), 413-426
    Aydogan Türkoğlu & Gültekin Tosun (2020) Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions, ADYU J SCI, 10(2), 413-426 Cloning of ADAMTS2 Gene and Colony Formation Effect of ADAMTS2 in Saos-2 Cell Line Under Normal and Hypoxic Conditions Sümeyye AYDOGAN TÜRKOĞLU1,*, Sinem GÜLTEKİN TOSUN2 1Balıkesir University, Faculty of Science and Literature, Department of Molecular Biology and Genetics, Balıkesir, Turkey [email protected], ORCID: 0000-0003-1754-0700 2Erciyes University, Institute of Health Sciences, Faculty of Veterinary Medicine, Department of Genetics, Kayseri, Turkey [email protected], ORCID: 0000-0002-3927-0089 Received: 03.05.2020 Accepted: 25.09.2020 Published: 30.12.2020 Abstract ADAMTS2 (a disintegrin and metalloproteinase with thrombospondin motifs 2), an N- propeptidase isoenzyme, is an enzyme involved in collagen biosynthesis by providing the amino ends of procollagen to be cut away. ADAMTS2 has anti-angiogenic activity as well as provides the processing of collagen. With this activity, it has become a target in cancer studies. Hypoxic regulation is a process that affects the expression of a large number of genes at the cellular level. Within the scope of our study, the cloning of the ADAMTS2 gene and its expression in Saos-2 (human bone carcinoma) cell line were performed ectopically. For this purpose, the transient transfection of the expression vector containing ADAMTS2 coding sequence was transfected by the calcium-phosphate precipitation method. Recombinant ADAMTS2 mRNA expression was checked by Real-Time PCR in Saos-2 cells. It was observed that there was a 50-fold increase in ADAMTS2 mRNA expression in the transfected Saos-2 cells compared to the control group.
    [Show full text]
  • Review Article
    REVIEW ARTICLE COLLAGEN METABOLISM COLLAGEN METABOLISM Types of Collagen 228 Structure of Collagen Molecules 230 Synthesis and Processing of Procollagen Polypeptides 232 Transcription and Translation 233 Posttranslational Modifications 233 Extracellular Processing of Procollagen and Collagen Fibrillogenesis 240 Functions of Collagen in Connective rissue 243 Collagen Degradation 245 Regulation of the Metabolism of Collagen 246 Heritable Diseases of Collagen 247 Recessive Dermatosparaxis 248 Recessive Forms of EDS 251 EDS VI 251 EDS VII 252 EDS V 252 Lysyl Oxidase Deficiency in the Mouse 253 X-Linked Cutis Laxa 253 Menke's Kinky Hair Syndrome 253 Homocystinuria 254 EDS IV 254 Dominant Forms of EDS 254 Dominant Collagen Packing Defect I 255 Dominant and Recessive Forms of Osteogenesis Imperfecta 258 Dominant and Recessive Forms of Cutis Laxa 258 The Marfan Syndrome 259 Acquired Diseases and Repair Processes Affecting Collagen 259 Acquired Changes in the Types of Collagen Synthesis 260 Acquired Changes in Amounts of Collagen Synthesized 263 Acquired Changes in Hydroxylation of Proline and Lysine 264 Acquired Changes in Collagen Cross-Links 265 Acquired Defects in Collagen Degradation 267 Conclusion 267 Bibliography 267 Collagen Metabolism A Comparison of Diseases of Collagen and Diseases Affecting Collagen Ronald R. Minor, VMD, PhD COLLAGEN CONSTITUTES approximately one third of the body's total protein, and changes in synthesis and/or degradation of colla- gen occur in nearly every disease process. There are also a number of newly described specific diseases of collagen in both man and domestic animals. Thus, an understanding of the synthesis, deposition, and turnover of collagen is important for the pathologist, the clinician, and the basic scientist alike.
    [Show full text]
  • WO 2013/126587 Al 29 August 2013 (29.08.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/126587 Al 29 August 2013 (29.08.2013) P O P C T (51) International Patent Classification: (74) Agents: MCANDREW, Christopher W. et al; Wilson A61K 38/00 (2006.01) Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, CA 94304-1050 (US). (21) International Application Number: PCT/US20 13/027 159 (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (22) International Filing Date: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, 2 1 February 2013 (21 .02.2013) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (25) Filing Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (26) Publication Language: English KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (30) Priority Data: ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 61/601,434 2 1 February 2012 (21.02.2012) US NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 61/726,815 15 November 2012 (15. 11.2012) US RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, 61/726,840 15 November 2012 (15. 11.2012) US TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, 61/727,433 16 November 2012 (16.
    [Show full text]
  • Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene Alain Colige,à Lieve Nuytinck,w Ingrid Hausser,z Anthonie J. van Essen,y Marc Thiry,z Christian Herens,# Lesley C. Ade` s,Ãà Fransiska Malfait,w Anne De Paepe,w Peter Franck,ww Gerhard Wolff,zz JanC.Oosterwijk,y J. H. Sillevis Smitt,yy Charles M. Lapie` re,à and Betty V. Nusgensà ÃLaboratory of Connective Tissues Biology, GIGA Research Center, University of Lie` ge, Lie` ge, Belgium; wCentrum voor Medische Genetica, Universitair Ziekenhuis, University of Gent, Gent, Belgium; zElectron Microscopic Laboratory, Department of Dermatology, University Heidelberg, Heidelberg, Germany; yDepartment of Clinical Genetics, University Medical Center, Groningen, The Netherlands; zLaboratoire de Biologie cellulaire et tissulaire, University of Lie` ge, Lie` ge, Belgium; #Center for Human Genetics, University of Lie` ge, Lie` ge, Belgium; ÃÃDepartment of Clinical Genetics, The Children’s Hospital at Westmead, and Discipline of Paediatrics and Child Health, University of Sydney, Sydney, Australia; wwDepartment of Pediatrics, University Freiburg, Freiburg, Germany; zzInstitute of Human Genetics and Anthropology, University Freiburg, Freiburg, Germany; yyDepartment of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Ehlers–Danlos syndrome (EDS) type VIIC, or dermatosparactic type, is a recessively inherited connective tissue disorder characterized, among other symptoms, by an extreme skin fragility resulting from mutations inactivating ADAMTS-2, an enzyme excising the aminopropeptide of procollagens type I, II, and III.
    [Show full text]
  • Vascular Phenotypes in Nonvascular Subtypes of the Ehlers-Danlos Syndrome: a Systematic Review
    SYSTEMATIC REVIEW Official journal of the American College of Medical Genetics and Genomics Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review Sanne D’hondt, MSc1, Tim Van Damme, MD1 and Fransiska Malfait, MD, PhD1 Purpose: Within the spectrum of the Ehlers-Danlos syndromes (53%), frequently reported in musculocontractural and classical- (EDS), vascular complications are usually associated with the like EDS; intracranial hemorrhages (18%), with a high risk in vascular subtype of EDS. Vascular complications are also observed dermatosparaxis EDS; and arterial dissections (16%), frequently in other EDS subtypes, but the reports are anecdotal and the reported in kyphoscoliotic and classical EDS. Other, more minor, information is dispersed. To better document the nature of vascular vascular complications were reported in cardiac-valvular, arthro- complications among “nonvascular” EDS subtypes, we performed chalasia, spondylodysplastic, and periodontal EDS. a systematic review. Conclusion: Potentially life-threatening vascular complications are Methods: We queried three databases for English-language a rare but important finding in several nonvascular EDS sub- studies from inception until May 2017, documenting both types, highlighting a need for more systematic documentation. This phenotypes and genotypes of patients with nonvascular EDS review will help familiarize clinicians with the spectrum of vascular subtypes. The outcome included the number and nature of vascular complications in EDS and guide follow-up and management. complications. Genet Med advance online publication 5 October 2017 Results: A total of 112 papers were included and data were collected from 467 patients, of whom 77 presented with a vascular Key Words: connective tissue disorder; Ehlers-Danlos syndrome; phenotype.
    [Show full text]
  • Reduction of Type V Collagen Using a Dominant-Negative
    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Reduction of Type V Collagen Using a Dominant-negative Strategy Alters the Regulation of Fibrillogenesis and Results in the Loss of Corneal-Specific Fibril Morphology Jeffrey K. Marchant, Rita A. Hahn, Thomas F. Linsenmayer, and David E. Birk Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts 02111 Abstract. A number of factors have been implicated in synthesized the truncated or(V) protein, and this was the regulation of tissue-specific collagen fibril diameter. detectable only intracellularly, in a distribution that Previous data suggest that assembly of heterotypic colocalized with lysosomes. To assess endogenous fibrils composed of two different fibrillar collagens rep- etl(V) protein levels, infected cell cultures were as- resents a general mechanism regulating fibril diameter. sayed, and these consistently demonstrated reductions Specifically, we hypothesize that type V collagen is re- relative to control virus-infected or uninfected cultures. quired for the assembly of the small diameter fibrils ob- Analyses of corneal fibril morphology demonstrated served in the cornea. To test this, we used a dominant- that the reduction in type V collagen resulted in the as- negative retroviral strategy to decrease the levels of sembly of large-diameter fibrils with a broad size distri- type V collagen secreted by chicken corneal fibroblasts. bution, characteristics similar to fibrils produced in The chicken or(V) collagen gene was cloned, and ret- connective tissues with low type V concentrations. Im- roviral vectors that expressed a polycistronic mRNA munoelectron microscopy demonstrated the amino- encoding a truncated otl(V) minigene and the reporter terminal domain of type V collagen was associated with gene LacZ were constructed.
    [Show full text]
  • The Procollagen N-Proteinases ADAMTS2, 3 and 14 in Pathophysiology
    Review The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology Mourad Bekhouche and Alain Colige Laboratory of Connective Tissues Biology, GIGA-R, University of Liège, B-4000 Sart Tilman, Belgium Correspondence to Alain Colige: Laboratory of Connective Tissues Biology, University of Liège, GIGA-Research, Tour de Pathologie B23/3, Avenue de l'Hôpital, 3, B-4000 Sart Tilman, Belgium. [email protected] http://dx.doi.org/10.1016/j.matbio.2015.04.001 Edited by W.C. Parks and S. Apte Abstract Collagen fibers are the main components of most of the extracellular matrices where they provide a structural support to cells, tissues and organs. Fibril-forming procollagens are synthetized as individual chains that associate to form homo- or hetero-trimers. They are characterized by the presence of a central triple helical domain flanked by amino and carboxy propeptides. Although there are some exceptions, these two propeptides have to be proteolytically removed to allow the almost spontaneous assembly of the trimers into collagen fibrils and fibers. While the carboxy-propeptide is mainly cleaved by proteinases from the tolloid family, the amino-propeptide is usually processed by procollagen N-proteinases: ADAMTS2, 3 and 14. This review summarizes the current knowledge concerning this subfamily of ADAMTS enzymes and discusses their potential involvement in physiopathological processes that are not directly linked to fibrillar procollagen processing. © 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Introduction determine the cause of dermatosparaxis, a rare genetic disease that appeared in Belgian cattle herds during an Fibrillar collagens are the most abundant proteins inbreeding program [2,3].
    [Show full text]
  • Understanding the Basis of Ehlers–Danlos Syndrome in the Era of the Next-Generation Sequencing
    Archives of Dermatological Research (2019) 311:265–275 https://doi.org/10.1007/s00403-019-01894-0 REVIEW Understanding the basis of Ehlers–Danlos syndrome in the era of the next-generation sequencing Francesca Cortini1,2 · Chiara Villa3 · Barbara Marinelli1 · Romina Combi3 · Angela Cecilia Pesatori1 · Alessandra Bassotti4 Received: 29 July 2018 / Revised: 26 November 2018 / Accepted: 12 February 2019 / Published online: 2 March 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Ehlers–Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs) defined by joint laxity, skin alterations, and joint hypermobility. The latest EDS classification recognized 13 sub- types in which the clinical and genetic phenotypes are often overlapping, making the diagnosis rather difficult and strength- ening the importance of the molecular diagnostic confirmation. New genetic techniques such as next-generation sequencing (NGS) gave the opportunity to identify the genetic bases of unresolved EDS types and support clinical counseling. To date, the molecular defects have been identified in 19 genes, mainly in those encoding collagen, its modifying enzymes or other constituents of the extracellular matrix (ECM). In this review we summarize the contribution of NGS technologies to the current knowledge of the genetic background in different EDS subtypes. Keywords Ehlers–Danlos syndrome · Heterogeneity · Heritable connective tissue disorders Introduction in 1988, represents the first attempt to classify EDS, recog- nizing 11 EDS subtypes [4], defined by Roman numerals and Ehlers–Danlos syndrome (EDS) comprises a clinically and classified according to clinical findings and the inheritance heterogeneous group of heritable connective tissue disor- pattern.
    [Show full text]
  • Collagen: a Brief Analysis REVIEW ARTICLE
    OMPJ 10.5005/jp-journals-10037-1143Collagen: A Brief Analysis REVIEW ARTICLE Collagen: A Brief Analysis 1Supriya Sharma, 2Sanjay Dwivedi, 3Shaleen Chandra, 4Akansha Srivastava, 5Pradkshana Vijay ABSTRACT Its adaptable role is due to its immense properties such as 1 Collagen is the most abounding structural protein in a human biocompatibility, biodegradability and easy availability. body representing 30% of its dry weight and is significant to They are centrally involved in the constructions of health because it designates the structure of skin, connective basement membranes along with diverse structures of the tissues, bones, tendons, and cartilage. Much advancement extracellular matrix, fibrillar and microfibrillar networks has been made in demonstrating the structure of collagen triple of the extracellular matrix. It establishes their fundamental helices and the physicochemical premise for their stability. Collagen is the protein molecule which produces the major part fractional monetary unit and identifies crucial steps in of the extracellular matrix. Artificial collagen fibrils that exhibit the biosynthesis and supramolecular preparing of fibril- some characteristics of natural collagen fibrils are now con- lar collagens.3 They are the most abundant structural gregated using chemical synthesis and self-aggregation. The component of the connective tissue and are present in all indigenous collagen fibrils lead further development of artificial multicellular organisms. In the light microscope, collagen collagenous materials for nanotechnology and biomedicine. fibers typically appear as the wavy structure of variable Keywords: Collagen, Structure of Collagen, Diagnostic Impor- width and intermediate length. tance, Collagen Disorders. They stain readily with eosin and other acidic dyes. How to cite this article: Sharma S, Dwivedi S, Chandra S, When examined with a transmission electron micro- Srivastava A, Vijay P.
    [Show full text]
  • Collagen Tissue Engineering: Development of Novel Biomaterials and Applications
    0031-3998/08/6305-0492 Vol. 63, No. 5, 2008 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2008 International Pediatric Research Foundation, Inc. Collagen Tissue Engineering: Development of Novel Biomaterials and Applications LIAN CEN, WEI LIU, LEI CUI, WENJIE ZHANG, AND YILIN CAO Department of Plastic and Reconstructive Surgery [W.L., L.C., W.Z., Y.C.], Shanghai 9th People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China; National Tissue Engineering Center of China [L.C., W.L., L.C., W.Z., Y.C.], Shanghai 200235, China ABSTRACT: Scientific investigations involving collagen have in- regeneration is to restore both the structural integrity and the spired tissue engineering and design of biomaterials since collagen vivid remodeling process of native ECM, especially restoring the fibrils and their networks primarily regulate and define most tissues. delicate collagen networks under which normal physiologic re- The collagen networks form a highly organized, three-dimensional generation occurs. architecture to entrap other ingredients. Biomaterials are expected to Collagen molecules have a triple-helical structure and the function as cell scaffolds to replace native collagen-based extracel- lular matrix. The composition and properties of biomaterials used as presence of 4-hydroxyproline resulting from a posttransla- scaffold for tissue engineering significantly affect the regeneration of tional modification of peptide-bound prolyl residues provides neo-tissues and influence the conditions of collagen engineering. The a distinctive marker of these molecules (2). To date, 28 complex scenario of collagen characteristics, types, fibril arrange- collagen types have been identified; I, II, III, and V are the ment, and collagen structure-related functions (in a variety of con- main types that make up the essential part of collagen in bone, nective tissues including bone, cartilage, tendon, skin and cornea) are cartilage, tendon, skin, and muscle.
    [Show full text]